Palisade Bio, Inc. (PALI) Financials

PALI Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 17.1 million 3.0 million
2023-06-30 18.3 million 2.5 million
2023-03-31 15.3 million 1.5 million
2022-12-31 15.8 million 3.3 million

PALI Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -2.7 million 202000
2023-06-30 -2.2 million 144000
2023-03-31 -3.5 million 93000
2022-12-31 -3.3 million 86000

PALI Net Income

No data available :(

PALI Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 15.3 million - 239000
2023-06-30 16.4 million - 266000
2023-03-31 13.3 million - 291000
2022-12-31 12.4 million - 316000

PALI Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 7.3 million
2023-06-30 6.4 million
2023-03-31 4.3 million
2022-12-31 880311

PALI Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 1.7 million 1.7 million -
2023-06-30 4000 2.2 million 1.4 million -
2023-03-31 4000 1.2 million 1.5 million -
2022-12-31 10000 2.3 million 1.5 million -

PALI Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 1000
2023-06-30 - 27000
2023-03-31 250000 26000
2022-12-31 - 26000

PALI

Price: $7.74

52 week price:
3.82
36.60

Earnings Per Share: -27.00 USD

P/E Ratio: 1.38

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 369800

Market Capitalization: 3.5 million

Links: